Evidence map›Paper›PMID 41401047›Full record

ArticleThe Biochemical journal2025

Expression and characterization of an endo-β-1,6-galactanase from Arabidopsis thaliana.

Koen Gistelinck, Xiaolan Yu, Arthur Leyder, Vinicius J S Osterne, Tom Desmet, Theodora Tryfona, Els J M Van Damme

Abstract read
In one paragraph

Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Crystal structure of endo-β-1,6-galactanase from Streptomyces avermitilis.Acta crystallographica. Section D, Structural biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Koen GistelinckLaboratory of Biochemistry and Glycobiology, Department of Biotechnology, Ghent University, Ghent, 9000, Belgium.ORCID 0000-0003-1047-1925
Xiaolan YuDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, U.K.ORCID 0000-0001-8245-8725
Arthur LeyderCentre for Synthetic Biology, Department of Biotechnology, Ghent University, Ghent, 9000, Belgium.ORCID 0000-0002-8667-254X
Vinicius J S OsterneDepartment of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Ceará, 60440-970, Brazil.ORCID 0000-0002-5730-8829
Tom DesmetCentre for Synthetic Biology, Department of Biotechnology, Ghent University, Ghent, 9000, Belgium.ORCID 0000-0002-5788-3022
Theodora TryfonaDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, U.K.ORCID 0000-0002-1618-3521
Els J M Van DammeLaboratory of Biochemistry and Glycobiology, Department of Biotechnology, Ghent University, Ghent, 9000, Belgium.ORCID 0000-0001-9848-766X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, only fungal and bacterial endo-β-1,6-galactanases from glycoside hydrolase subfamilies GH5_16 and GH30_5 have been characterized. β-1,6-galactan chains are primarily structural components of type II arabinogalactans present in plant and algal cell walls. The ATIYA1 gene, originating from Arabidopsis thaliana, was cloned and expressed in Komagataella phaffii. The precursor protein consists of an N-terminal signal peptide, a glycosyl hydrolase domain, and a C-terminal ricin B-like module. The recombinant enzyme was able to hydrolyze β-1,6-linked galactan chains. Optimal conditions for enzymatic activity were observed at pH 5 and 30°C. The ATIYA1 gene encodes the first endo-β-1,6-galactanase identified from plants and represents the first characterized member within the GH5_11 subfamily.

Indexed as

ArabidopsisArabidopsis ProteinsGlycoside HydrolasesAmino Acid SequenceCloning, MolecularGalactansRecombinant ProteinsArabidopsis ProteinsGalactansGlycoside HydrolasesRecombinant ProteinsArabidopsis thalianaendo-β-1,6-galactanaseenzyme specificityglycosyl hydrolasemolecular dynamics

Identifiers

PMID41401047
PMCPMC12751061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.